ACE Inhibitor Cough — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Increased bradykinin levels
ACE inhibitor-induced cough affects 5–20% of patients and is caused by accumulation of bradykinin and substance P in the lungs, which are normally degraded by ACE. This leads to increased cough reflex sensitivity. The cough typically resolves within 1–4 weeks of cessation. Switching to an ARB (which does not affect bradykinin metabolism) is appropriate. The cough is more common in women and patients of East Asian descent.
Reference: AMH – 2025 – ACE Inhibitors; eTG – 2025 – Cardiovascular